Trial NCT01467479

View at ClinicalTrials.gov 
Org. Study IDs: VX11-950-115

Last trial update was posted on 2015-03-17

MeSH Interventions

Anti-Retroviral Agents Interferon alpha-2 Interferon-alpha Interferons Peginterferon alfa-2a Ribavirin

MeSH Conditions

Hepatitis Hepatitis A Hepatitis C

Other Conditions


Stopping Reasons

It was decided by Sponsor on 13 January 2014 to terminate study early at primary efficacy endpoint as part of a decision to modify drug development plan.

Limitations And Caveats

It was decided by Sponsor on 13 January 2014 to terminate the study early at the primary efficacy endpoint (SVR12) as part of a decision to modify the drug development plan. Eligible participants completed virologic follow-up after termination.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID